Description

Rac-(13Ar*)-2,3-Dimethoxy-5,8,13,13A-Tetrahydro-6H-Dibenzo[A,G]Quinolizine CAS NO 47206-72-4 is a complex, chiral tetrahydroisoquinoline derivative of significant interest in advanced organic synthesis and pharmaceutical research. This compound serves as a sophisticated synthetic intermediate or a key structural motif for developing novel bioactive molecules. It is primarily sought after by research chemists and process development teams in the pharmaceutical and fine chemical industries. Its unique dibenzoquinolizine scaffold makes it valuable for exploring new chemical spaces in drug discovery programs.

Application

• Pharmaceutical Intermediate: Acts as a crucial building block for the synthesis of potential alkaloid-based therapeutics and central nervous system (CNS) active compounds.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and the development of new chemical entities (NCEs) targeting various biological pathways.
• Asymmetric Synthesis: Used as a starting material or chiral template in the development of enantioselective synthetic routes for complex molecules.
• Chemical Reference Standard: Employed as an analytical standard in quality control and method development for related pharmaceutical processes.
• Academic Research: Utilized in universities and research institutes for studying organic reaction mechanisms, natural product synthesis, and heterocyclic chemistry.

Basic Information

Product Name	Rac-(13Ar*)-2,3-Dimethoxy-5,8,13,13A-Tetrahydro-6H-Dibenzo[A,G]Quinolizine
CAS No.	47206-72-4
Molecular Formula	C19H21NO2
Molecular Weight	295.38 g/mol
Synonyms	2,3-Dimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine (racemic); (±)-2,3-Dimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; rac-2,3-Dimethoxytetrahydrodibenzo[a,g]quinolizine; DL-2,3-Dimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; Tetrahydroprotoberberine derivative; 6H-Dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3-dimethoxy-, (±)-; Contact for EINECS details.

Quality Control

Our Rac-(13Ar*)-2,3-Dimethoxy-5,8,13,13A-Tetrahydro-6H-Dibenzo[A,G]Quinolizine is produced under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research applications. Each batch undergoes comprehensive analytical characterization, including HPLC for purity and NMR for structural confirmation. A detailed Certificate of Analysis (COA) is provided, documenting identity, purity, and impurity profiles. We support our clients' regulatory needs with full traceability and documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flames. For long-term storage, consider storing under an inert atmosphere to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.